Us Bancorp \De\ Crispr Therapeutics Ag Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Us Bancorp \De\ holds 2,589 shares of CRSP stock, worth $123,961. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,589

Previous 5,817 55.49%

Holding current value

$123,961

Previous $314,000 61.46%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$44.62 - $62.75 $144,033 - $202,557	-3,228 Reduced 55.49%	2,589 $121,000
Q2 2024 Aug 06, 2024	SELL	$51.17 - $68.18 $1,228 - $1,636	-24 Reduced 0.41%	5,817 $314,000
Q1 2024 May 07, 2024	SELL	$60.67 - $89.12 $485 - $712	-8 Reduced 0.14%	5,841 $398,000
Q4 2023 Feb 09, 2024	SELL	$38.62 - $72.18 $19,078 - $35,656	-494 Reduced 7.79%	5,849 $366,000
Q3 2023 Nov 03, 2023	SELL	$45.39 - $59.0 $20,516 - $26,668	-452 Reduced 6.65%	6,343 $287,000
Q2 2023 Aug 09, 2023	SELL	$43.47 - $67.77 $32,819 - $51,166	-755 Reduced 10.0%	6,795 $381,000
Q1 2023 May 09, 2023	BUY	$41.0 - $56.12 $27,019 - $36,983	659 Added 9.56%	7,550 $341,000
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $251,795 - $421,929	-6,425 Reduced 48.25%	6,891 $280,000
Q3 2022 Oct 27, 2022	BUY	$61.1 - $83.78 $277,943 - $381,115	4,549 Added 51.89%	13,316 $870,000
Q2 2022 Aug 01, 2022	SELL	$43.23 - $73.83 $32,811 - $56,036	-759 Reduced 7.97%	8,767 $533,000
Q1 2022 May 11, 2022	BUY	$53.19 - $79.24 $46,062 - $68,621	866 Added 10.0%	9,526 $598,000
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $102,611 - $162,928	1,464 Added 20.34%	8,660 $657,000
Q3 2021 Nov 10, 2021	BUY	$110.2 - $156.64 $150,643 - $214,126	1,367 Added 23.45%	7,196 $805,000
Q2 2021 Aug 05, 2021	BUY	$100.84 - $161.89 $60,403 - $96,972	599 Added 11.45%	5,829 $944,000
Q1 2021 Apr 28, 2021	BUY	$110.72 - $210.04 $439,890 - $834,488	3,973 Added 316.07%	5,230 $638,000
Q4 2020 Feb 04, 2021	BUY	$79.67 - $173.23 $4,939 - $10,740	62 Added 5.19%	1,257 $193,000
Q3 2020 Nov 10, 2020	SELL	$78.5 - $100.64 $86,350 - $110,704	-1,100 Reduced 47.93%	1,195 $100,000
Q1 2020 May 13, 2020	BUY	$33.68 - $62.53 $4,210 - $7,816	125 Added 5.76%	2,295 $97,000
Q4 2019 Feb 04, 2020	BUY	$36.68 - $73.13 $73,360 - $146,260	2,000 Added 1176.47%	2,170 $132,000
Q3 2019 Nov 08, 2019	SELL	$40.99 - $52.56 $18,486 - $23,704	-451 Reduced 72.62%	170 $7,000
Q2 2019 Aug 13, 2019	BUY	$35.45 - $48.2 $18,646 - $25,353	526 Added 553.68%	621 $29,000
Q3 2018 Nov 01, 2018	BUY	$44.35 - $65.71 $4,213 - $6,242	95 New	95 $4,000

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account